CRISPR Therapeutics AG

Advisory Services Network, LLC CRSP

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/17/2026

Shares

14,844

Value ($000)

778

Weight

0.0%

2019 Q4 - 2025 Q4 (24 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/17/2026	778	0.0%	14,844	12/31/2025
2025 Q3	11/18/2025	896	0.0%	13,820	9/30/2025
2025 Q2	8/19/2025	758	0.0%	13,470	6/30/2025
2025 Q1	5/15/2025	339	0.0%	9,961	3/31/2025
2024 Q4	2/13/2025	396	0.0%	10,057	12/31/2024
2024 Q3	11/14/2024	955	0.0%	17,686	9/30/2024
2024 Q2	8/13/2024	955	0.0%	17,686	6/30/2024
2024 Q1	5/6/2024	1,198	0.0%	17,574	3/31/2024
2023 Q4	2/9/2024	1,106	0.0%	17,674	12/31/2023
2023 Q3	11/14/2023	627	0.0%	13,820	9/30/2023
2023 Q2	8/9/2023	815	0.0%	14,526	6/30/2023
2023 Q1	5/17/2023	649	0.0%	14,356	3/31/2023
2022 Q4	2/13/2023	100	0.0%	2,449	12/31/2022
2022 Q3	11/14/2022	202	0.0%	3,084	9/30/2022
2022 Q2	8/2/2022	382	0.0%	6,287	6/30/2022
2022 Q1	5/23/2022	842	0.0%	13,420	3/31/2022
2021 Q4	2/14/2022	936	0.0%	12,351	12/31/2021
2021 Q3	11/5/2021	1,431	0.0%	12,786	9/30/2021
2021 Q2	8/12/2021	2,015	0.1%	12,449	6/30/2021
2021 Q1	5/24/2021	1,238	0.0%	10,158	3/31/2021
2020 Q4	2/9/2021	1,272	0.1%	8,310	12/31/2020
2020 Q3	11/16/2020	95	0.0%	1,141	9/30/2020
2020 Q1	5/15/2020	29	0.0%	674	3/31/2020
2019 Q4	2/4/2020	41	0.0%	674	12/31/2019